DDEVFINANCE STUDENT

EQUITY RESEARCH / NYSE: VST / REPORT DATE APR 4, 2026

Vistra: catalyst-led power thesis

DCF and peer-relative valuation with the dated assumptions and evidence gaps made explicit.

Research question
Can operating catalysts close the report-date value gap?
Method
60% DCF / 40% relative valuation
Report-date view
BUY at $153.79 / $208 target
Status
Dated thesis; not re-rated
Last review
Jul 27, 2026

Evidence status

FieldRecorded status
Report dateApr 4, 2026
Data basisFY2025 actuals and report-disclosed FY2026–FY2028 estimates
Last portfolio reviewJul 27, 2026
Thesis statusOriginal dated thesis plus undated follow-up visual; observation date unstated; not re-rated
Current-market statusIntentionally not shown

Investment thesis

The report links potential operating catalysts—quarterly results, the anticipated Cogentrix close and synergy update, and hyperscaler demand agreements—to Vistra’s diversified generation and retail footprint.

Valuation and assumptions

Vistra valuation bridge showing DCF, relative valuation, and blended target
Disclosed outputs from the dated report. The underlying cash-flow model is not public.
AssumptionReport valueEvidence boundary
Report-date price$153.79Dated Apr 4, 2026
DCF value$193.79Output disclosed; full forecast not public
Relative valuation$229.31Peer-median blend disclosed
Weights60% DCF / 40% relativeReproduced in workbook
WACC13.0%Disclosed
Exit EV/EBITDA15.5xDisclosed
FY2028 EBITDA$9.2BReport estimate

Catalysts and risks

Catalysts

  • Quarterly operating and cash-flow evidence.
  • Cogentrix close and synergy communication.
  • Hyperscaler demand agreements.

Risks

  • FERC and contract regulation.
  • Supplier, tariff, integration, and outage execution.
  • Valuation and sentiment after a large prior move.

Thesis invalidation

Weakening operating evidence, failed integration, materially lower cash-flow expectations, or catalysts that do not translate into durable earnings would challenge the report’s mechanism.

Sources and limitations

Authorship & source boundary

The thesis, valuation blend, and interpretation are Dev Pandya’s educational analysis. Company facts, SEC filings, and licensed Bloomberg fields remain attributable to their original publishers. Bloomberg terminal pages in the report appendix are classified as licensed source material and are not represented as Dev’s authorship.

EvidenceSourceUse
Primary analysis27-page reportDev’s dated thesis, valuation, and source-classified appendix
FY2025 Form 10-KFiled Feb 27, 2026 · Accession 0001692819-26-000006 ↗Official annual financial, asset, and risk disclosures
Q1 2026 Form 10-QFiled May 8, 2026 · Accession 0001692819-26-000014 ↗Official interim disclosure; post-dates the Apr 4 report
Investor relationsVistra IR ↗Issuer-authored company materials
Licensed data classificationBloomberg DES, ESG, RV, profitability, and SPLC appendix pagesThird-party licensed source material; not Dev-authored and not redistributed separately
Follow-upSource visualDev commentary; source and observation dates absent

Downloads

27-page report PDF ↗Valuation bridge XLSX ↓Follow-up visual ↗

EDUCATIONAL OR ACADEMIC WORK / DATED OR HYPOTHETICAL EVIDENCE / NOT CURRENT MARKET DATA / NOT INVESTMENT ADVICE